Abstract

BackgroundThis study aims to construct and validate a model based on convolutional neural networks (CNNs), which can fulfil the automatic segmentation of clinical target volumes (CTVs) of breast cancer for radiotherapy.MethodsIn this work, computed tomography (CT) scans of 110 patients who underwent modified radical mastectomies were collected. The CTV contours were confirmed by two experienced oncologists. A novel CNN was constructed to automatically delineate the CTV. Quantitative evaluation metrics were calculated, and a clinical evaluation was conducted to evaluate the performance of our model.ResultsThe mean Dice similarity coefficient (DSC) of the proposed model was 0.90, and the 95th percentile Hausdorff distance (95HD) was 5.65 mm. The evaluation results of the two clinicians showed that 99.3% of the chest wall CTV slices could be accepted by clinician A, and this number was 98.9% for clinician B. In addition, 9/10 of patients had all slices accepted by clinician A, while 7/10 could be accepted by clinician B. The score differences between the AI (artificial intelligence) group and the GT (ground truth) group showed no statistically significant difference for either clinician. However, the score differences in the AI group were significantly different between the two clinicians. The Kappa consistency index was 0.259. It took 3.45 s to delineate the chest wall CTV using the model.ConclusionOur model could automatically generate the CTVs for breast cancer. AI-generated structures of the proposed model showed a trend that was comparable, or was even better, than those of human-generated structures. Additional multicentre evaluations should be performed for adequate validation before the model can be completely applied in clinical practice.

Highlights

  • Breast cancer is one of the most common malignant tumours in women

  • The results given by clinician A show that 99.3% of the chest wall clinical target volume (CTV) slices from the artificial intelligence (AI) group, and all the chest wall CTV slices from the GT group, can be accepted

  • The evaluation results from clinician B show that 98.9% of the chest wall CTV slices from the AI group, and all the chest wall CTV slices from the GT group, can be accepted

Read more

Summary

Introduction

Breast cancer is one of the most common malignant tumours in women. It was estimated that there were 2.1 million newly diagnosed female breast cancer cases, and 0.6 million cancer deaths in 2018 [1]. The precise delineation of the clinical target volume (CTV) is an essential step for accurate, individualized treatment. This task is time consuming and largely relies on the experience of oncologists. With the development of adaptive radiotherapy in recent years, clinicians are required to delineate the CTV accurately in a short time. Facing these new challenges, the application of artificial intelligence (AI) in radiotherapy may provide a feasible solution. This study aims to construct and validate a model based on convolutional neural networks (CNNs), which can fulfil the automatic segmentation of clinical target volumes (CTVs) of breast cancer for radiotherapy

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call